Board of Directors

Bob Rieder
Chairman and CEO, Cardiome Pharma

Bob Rieder is currently Chairman and Chief Executive Officer of Cardiome Pharma. Prior to his long and successful tenure as Cardiomes' Chief Executive he has extensive experience in venture capital and operational management. Mr. Rieder has served as Chief Operating Officer of DBA Telecom, Chief Executive Officer of Synapse Technologies, and as a director in numerous public and private technology companies.

Gordon H. Busenbark
Chief Financial Officer, Xytis Pharmaceuticals

Gordon H. Busenbark is currently Chief Financial Officer of Xytis Pharmaceuticals, and has previously served as Chief Financial Officer of Encysive Pharmaceuticals. Mr. Busenbark has also held various financial, operational and general management positions at Baxter Healthcare for over 20 years.

Beng Lai

Beng Lai is the founder and President of Intrynsyc Capital Corporation, a registered Canadian securities dealer that provides investment banking services to growth companies and accredited investors.  He was previously an investment banker at Jennings Capital Inc. with responsibility for the healthcare/biotechnology, technology and industrial sectors.  His prior investment banking experience was with Barclays de Zoete Wedd Ltd. and N.M. Rothschild & Sons Ltd., both in the UK.  He has also been the investment manager of a Canadian venture capital fund and has had board positions in public and private companies in Canada.  Beng has a degree in Dental Surgery and a Masters in Business Administration.